News Column

AEGERION PHARMACEUTICALS, INC. FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

June 26, 2014



Item 5.07 Submission of Matters to a Vote of Security Holders.

Aegerion Pharmaceuticals, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting") on June 25, 2014. At the Annual Meeting, the Company's stockholders elected Sol J. Barer, Ph.D. and Antonio M. Gotto, Jr., M.D., Ph.D. as Class I directors, to serve on the Board of Directors of the Company until the Company's 2017 Annual Meeting of Stockholders, and until their successors are duly elected and qualified. The voting results for this proposal were as follows:

For Withheld Broker Non-Votes Sol J. Barer, Ph.D. 18,897,489 5,403,613 1,920,491 Antonio M. Gotto, Jr., M.D., Ph.D. 21,344,080 2,957,022 1,920,491



In addition, at the Annual Meeting, the Company's stockholders voted to approve, in an advisory (non-binding) vote, the Company's executive compensation as disclosed in the Company's proxy statement, as filed with the Securities and Exchange Commission on April 30, 2014.

For Against Abstaining Broker Non-Votes 23,172,575 1,126,725 1,802 1,920,491



In addition, at the Annual Meeting, the Company's stockholders voted to ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014. The voting results for this proposal were as follows:

For Against Abstaining Broker Non-Votes 26,144,329 75,345 1,919 0



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters